The human prothrombin kringle-2 derived peptide, NSA9, is internalized into bovine capillary endothelial cells through endocytosis and energy-dependent pathways

Biochemical and Biophysical Research Communications

Volumn 335, Issue 2, 2005, Pages 469-476

  Hyun, Sook Hwang ^a   Soung, Soo Kim ^a  

^a Yonsei University   (South Korea)

Author keywords

Basic fibroblast growth factor; Bovine capillary endothelial cells; Endocytosis; Human prothrombin kringle 2; Internalization mechanism; Peptide

Indexed keywords

ADENOSINE TRIPHOSPHATE; ASPARAGINYLSERYLALANYLVALYLGLUTAMINYLLEUCYLVALYLGLUTAMYLASPARAGINE; CHLOROQUINE; LACTATE DEHYDROGENASE; NOCODAZOLE; PEPTIDE; PEPTIDE DERIVATIVE; PROTHROMBIN KRINGLE 2; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIUM; CELL MEMBRANE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; ENZYME ASSAY; ENZYME RELEASE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; INCUBATION TIME; INTERNALIZATION; KRINGLE DOMAIN; LOW TEMPERATURE; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CAPILLARIES; CATTLE; CELL MEMBRANE; CELL PROLIFERATION; CHLOROQUINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; HUMANS; KRINGLES; L-LACTATE DEHYDROGENASE; MICROSCOPY, FLUORESCENCE; NOCODAZOLE; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; PROTHROMBIN; SIGNAL TRANSDUCTION; TEMPERATURE; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

BOVINAE;

EID: 23744487017     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.07.090     Document Type: Article

References (49)

1. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1 1995 27 31
2. T. Browder, J. Folkman, and S. Pirie-Shepherd The hemostatic system as a regulator of angiogenesis J. Biol. Chem. 275 2000 1521 1524
3. J. Folkman, Y. Shing, and Angiogenesis J. Biol. Chem. 267 1992 10931 10934
4. Y. Cao, R.W. Ji, D. Davidson, J. Schaller, D. Marti, S. Söhndel, S.G. McCance, M.S. O'Reilly, M. Llinás, and J. Folkman Kringle domains of human angiostatin: characterization of the anti-proliferative activity on endothelial cells J. Biol. Chem. 271 1996 29461 29467
5. D.J. Good, P.J. Polverini, F. Rastinejad, M.M. Le Beau, R.S. Lemons, W.A. Frazier, and N.P. Bouck A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin Proc. Natl. Acad. Sci. USA 87 1990 6624 6628
6. M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, W.S. Lane, E. Flynn, J.R. Birkhead, B.R. Olsen, and J. Folkman Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
7. A. Bikfalvi Platelet factor 4: an inhibitor of angiogenesis Semin. Thromb. Hemost. 30 2004 379 385
8. T.H. Lee, T. Rhim, and S.S. Kim Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells J. Biol. Chem. 273 1998 28805 28812
9. N. Ferrara Role of vascular endothelial growth factor in regulation of physiological angiogenesis Am. J. Physiol. Cell Physiol. 280 2001 C1358 C1366
10. D.W. Dawson, S.F.A. Pearce, R. Zhong, R.L. Silverstein, W.A. Frazier, and N.P. Bouck CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells J. Cell Biol. 138 1997 707 717
11. 1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells Cancer Res. 62 2002 5580 5589
12. T. Sasaki, H. Larsson, J. Kreuger, M. Salmivirta, L. Claesson-Welsh, U. Lindahl, E. Hohenester, and R. Timpl Structural basis and potential role of hepain/hepain sulfate binding to the angiogenesis inhibitor endostatin EMBO J. 18 1999 6240 6248
13. A. Olsson, I. Johansson, H. Åkerud, B. Einarsson, R. Christofferson, T. Sasaki, R. Timpl, and L. Claesson-Welsh The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization Cancer Res. 64 2004 9012 9017
14. S. Richard-Blum, O. Féraud, H. Lortat-Jacob, A. Rencurosi, N. Futaki, F. Dkhissi, D. Vittet, A. Imberty, B.R. Olsen, and M. van der Rest Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations J. Biol. Chem. 279 2004 2927 2936
15. 3 in endothelial cells J. Biol. Chem. 276 2001 39562 39568
16. T.L. Moser, M.S. Stack, I. Asplin, J.J. Enghild, P. Højrup, L. Everitt, S. Hubchak, H.W. Schnaper, and S.V. Pizzo Angiostatin binds ATP synthase on the surface of human endothelial cells Proc. Natl. Acad. Sci. USA 96 1999 2811 2816
17. B. Troyanovsky, T. Levchenko, G. Månsson, O. Matvijenko, and L. Holmgren Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation J. Cell Biol. 152 2001 1247 1254
18. G.P. Tuszynski, M.R. Sharma, V.L. Rothman, and M.C. Sharma Angiostain binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells Microvasc. Res. 64 2002 448 462
19. K.S. Kim, Y.K. Hong, Y.A. Joe, Y. Lee, J.Y. Shin, H.E. Park, I.H. Lee, S.Y. Lee, D.K. Kang, S.I. Chang, and S.I. Chung Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells J. Biol. Chem. 278 2003 11449 11456
20. T.H. Kim, E. Kim, D. Yoon, J. Kim, T.Y. Rhim, and S.S. Kim Recombinant human prothrombin kringles have potent anti-angiogenic activities and inhibit Lewis lung carcinoma tumor growth and metastases Angiogenesis 5 2002 191 201
21. B.J. Kim, S.Y. Koo, and S.S. Kim A peptide derived from human prothrombin fragment 2 inhibits prothrombinase and angiogenesis Thromb. Res. 106 2002 81 87
22. C.D. Chang, and J. Meienhofer Solid-phase peptide synthesis using mild base cleavage of N alpha-fluorenylmethyloxycarbonylamino acids, exemplified by a synthesis of dihydrosomatostatin Int. J. Pept. Protein Res. 11 1978 246 249
23. D.T. Vistica, P. Skehan, D. Scudiero, A. Monks, A. Pittman, and M.R. Boyd Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production Cancer Res. 51 1991 2515 2520
24. T. Suzuki, S. Futaki, M. Niwa, S. Tanaka, K. Ueda, and Y. Sugiura Possible existence of common internalization mechanisms among arginine-rich peptides J. Biol. Chem. 277 2002 2437 2443
25. C. Korzeniewski, and D.M. Callewaert An enzyme-release assay for natural cytotoxicity J. Immunol. Methods 64 1983 313 320
26. S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, and Y. Sugiura Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J. Biol. Chem. 276 2001 5836 5840
27. J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V. Chernomordik, and B. Lebleu Cell-penetrating peptides: a reevaluation of the mechanism of cellular uptake J. Biol. Chem. 278 2003 585 590
28. Y. Guo, A.A. Higazi, A. Arakelian, B.S. Sachais, D. Cines, R.H. Goldfarb, T.R. Jones, H. Kwaan, A.P. Mazar, and S.A. Rabbani A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo FASEB J. 14 2000 1400 1410
29. G.S. Sheppard, M. Kawai, R.A. Craig, D.J. Davidson, S.M. Majest, R.L. Bell, and J. Henkin Lysyl 4-aminobenzoic acid derivatives as potent small molecule mimetics of plasminogen kringle 5 Bioorg. Med. Chem. Lett. 14 2004 965 966
30. P. O-Charoenrat, P. Rhys-Evans, and S. Eccles A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops Int. J. Cancer 100 2002 527 533
31. S.A. Wickström, K. Alitalo, and J. Keski-Oja An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells J. Biol. Chem. 279 2004 20178 20185
32. V. Jouan, X. Canron, M. Alemany, J.P. Caen, G. Quentin, J. Plouet, and A. Bikfalvi Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action Blood 94 1999 984 993
33. M. Hagedorn, L. Zilberberg, R.M. Lozano, P. Cuevas, X. Canron, M. Redondo-Horcajo, G. Giménez-Gallego, and A. Bikfalvi A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2 FASEB J. 15 2001 550 552
34. S.S. Tolsma, O.V. Volpert, D.J. Good, W.A. Frazier, P.J. Polverini, and N. Bouck Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity J. Cell Biol. 122 1993 497 511
35. M. Tyagi, M. Rusnati, M. Presta, and M. Giacca Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans J. Biol. Chem. 276 2001 3254 3261
36. A. Eguchi, T. Akuta, H. Okuyama, T. Senda, H. Yokoi, H. Inokuchi, S. Fujita, T. Hayakawa, K. Takeda, M. Hasegawa, and M. Nakanishi Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells J. Biol. Chem. 276 2001 26204 26210
37. P. Säälik, A. Elmquist, M. Hansen, K. Padari, K. Saar, K. Viht, Ü. Langel, and M. Pooga Protein cargo delivery properties of cell-penetrating peptides. A comparative study Bioconjug. Chem. 15 2004 1246 1253
38. Y. Liu, M. Jones, C.M. Hingtgen, G. Bu, N. Laribee, R.E. Tanzi, R.D. Moir, A. Nath, and J.J. He Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands Nat. Med. 6 2000 1380 1387
39. D. Derossi, S. Calvet, A. Trembleau, A. Brunissen, G. Chassaing, and A. Prochiantz Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent J. Biol. Chem. 271 1996 18188 18193
40. R. Tréhin, U. Krauss, R. Muff, M. Meinecke, A.G. Beck-Sickinger, and H.P. Merkle Cellular internalization of human calcitonin derived peptides in MDCK monolayer: a comparative study with Tat (47-57) and penetratin (43-58) Pharm. Res. 21 2004 33 42
41. I. Nakase, M. Niwa, T. Takeuchi, K. Sonomura, N. Kawabata, Y. Koike, M. Takehashi, S. Tanaka, K. Ueda, J.C. Simpson, A.T. Jones, Y. Sugiura, and S. Futaki Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement Mol. Ther. 10 2004 1011 1022
42. E. Skrzypek, C. Cowan, and S.C. Straley Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus Mol. Microbiol. 30 1998 1051 1065
43. N. Bayer, D. Schober, E. Prchla, R.F. Murphy, D. Blaas, and R. Fuchs Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection J. Virol. 72 1998 9645 9655
44. S.L. Kozak, S.E. Kuhmann, E.J. Platt, and D. Kabat Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1 J. Biol. Chem. 274 1999 23499 23507
45. D.A. Richards, S.O. Rizzoli, and W.J. Betz Effects of wortmannin and latrunculin A on slow endocytosis at the frog neuromuscular junction J. Physiol. 557 2004 77 91
46. E. Afonina, R. Stauber, and G.N. Pavlakis The human poly(A)-binding protein 1 shuttles between the nucleus and the cytoplasm J. Biol. Chem. 273 1998 13015 13021
47. J.A. Gutierrez, R.S. Inman, T. Akompong, J. Yu, and M. Wessling-Resnick Metabolic depletion inhibits the uptake of nontrasferrin-bound iron by K562 cells J. Cell. Physiol. 177 1998 585 592
48. K.H. Downing, and E. Nogales Crystallographic structure of tubulin: implication for dynamics and drug binding Cell Struct. Funct. 24 1999 269 275
49. I. Decordier, L. Dillen, E. Cundari, and M. Kirsch-Volders Elimination of micronucleated cells by apoptosis after treatment with inhibitors of microtubules Mutagenesis 17 2002 337 344